InspireMD signals potential FDA decisions in Q4 2026 while targeting $9M in annual cost savings — See source for full details.
$NSPR
Price history, market instrument context, member research, and related headlines in one place.
NSPR key statistics
NasdaqCMUSD
52-week range
$0.460%$2.42
Latest session $0.46–$0.50InspireMD, Inc. (NSPR) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $0.468, down $0.03 (6.40%) from the previous close of $0.50. It has traded between $0.46 and $0.50 in the latest session. Over the past year it has ranged from $0.46 to $2.42, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 198.7K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
InspireMD GAAP EPS of -$0.17, revenue of $1.77M misses by $0.36M — See source for full details.
InspireMD Q2 2026 Earnings Preview — See source for full details.
Loading $NSPR research…